                                                                                                                                                    Article

                                                                                                                             pubs.acs.org/biochemistry




Mechanism Feedback Allosteric Inhibition ATP
Phosphoribosyltransferase nia PedrenÌƒo,â€  JoaoÌƒ Pedro Pisco,â€  Ge ?rald Larrouy-Maumus,â€  Geoï¬€ Kelly,â€¡ Luiz Pedro ?rio Carvalho*,â€ 
â€ 
Mycobacterial Research Division, MRC National Institute Medical Research, â€¡MRC Biomolecular NMR Centre, Ridgeway, Hill, London NW7 1AA, U.K.




    ABSTRACT: MtATP-phosphoribosyltransferase catalyzes ï¬?rst committed step L-histidine biosynthesis     Mycobacterium tuberculosis subjected allosteric feedback regulation. essentiality, enzyme
    studied potential target novel anti-infectives. understand basis regulation, characterized     allosteric inhibition using gel ï¬?ltration, steady-state pre-steady-state kinetics, pH dependence inhibition     binding. Gel ï¬?ltration experiments indicate MtATP-phosphoribosyltransferase hexamer solution, presence     absence L-histidine. Steady-state kinetic studies demonstrate L-histidine inhibition uncompetitive versus ATP     noncompetitive versus PRPP. pH values close neutrality, Kii value 4 Î¼M obtained L-histidine. Pre-steady-state
    kinetic experiments indicate chemistry rate-limiting overall reaction L-histidine inhibition caused     trapping enzyme inactive conformation. pH dependence binding, obtained nuclear magnetic resonance,
    indicates L-histidine binds better neutral Î±-amino group. pH dependence inhibition (Kii), contrary,
    indicates L-histidine better inhibits MtATP-phosphoribosytransferase neutral imidazole ionized Î±-amino
    group. results combined model accounts allosteric inhibition MtATP-phosphoribosyltransferase.


                                                                            active site enzyme deemed  targetableâ€? poor
F    eedback allosteric inhibition metabolic enzymes      eï¬ƒcient mechanisms maintained evolution control ï¬‚ux biochemical pathways.1âˆ’3
                                                                            â€œligandabilityâ€?.7,8 examples important enzymes                                                                             successfully targeted allosteric site pyruvate
Eï¬ƒciency comes direct, speciï¬?c, nearly instanta-                 kinase  potential antihyperglycemic therapy),9 mitotic
neous eï¬€ect, permits dynamic control ï¬‚ux               kinesin (involved centrosome separation formation biochemical pathways. addition, feedback inhibition                   bipolar mitotic spindle),10 Staphylococcus aureus D-
independent transcription, translation, intricate signal             alanine:D-alanine ligase (involved peptidoglycan biosyn-
transduction cascades.                                                      thesis),11 Cdc34 ubiquitin-conjugatin enzyme (active
   Natural feedback inhibitors serve templates              certain prostate colorectal cancer cell lines),12 chemically diverse, allosteric small molecule inhibitors,             Haemophilus inf luenzae HslUV protease  bacterial version currently intensely sought probes chemical biology               proteosome).13 chemical genetics, regulators synthetic biology,                remarkable example allosterically regulated enzyme therapeutics diseases. addition qualities          ATP phosphoribosyltransferase (ATP-PRT), encoded described  allosteric inhibitors display                  hisG gene Mycobacterium tuberculosis. MtATP-PRT catalyzes
appealing features small molecule therapeutics. instance,            ï¬?rst committed step L-histidine biosynthesis (Scheme 1)
allosteric inhibitors potential noncompetitive            inhibited end product pathway, L-
uncompetitive versus particular substrate4 time-depend-
ent5,6 target sites enzyme active              Received: June 18, 2012
site. reasons, allosteric inhibitors target              Revised: August 22, 2012
feedback site compounds choice                     Published: September 18, 2012

                               Â© 2012 American Chemical Society      8027                       dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027âˆ’8038
 Biochemistry                                                                                                                                        Article

Scheme 1                                                                   validation, e., essentiality reaction pathway
                                                                           M. tuberculosis, conï¬?rmed high-resolution
                                                                           transposon mutagenesis18 clean genetic knockouts                                                                            enzymes pathway.19 addition, pathway absent                                                                            humans, suggests priori toxicity associated                                                                            potential inhibitors.
                                                                              ATP-PRTs (EC 2.4.2.17) catalyze reversible, Mg2+-
                                                                           dependent formation 1-(5-phospho-Î±-D-ribosyl)-ATP (PR-
                                                                           ATP) inorganic pyrophosphate (PPi) ATP 5-
                                                                           phospho-Î±-D-ribosyl pyrophosphate (PRPP) (Scheme 2).
                                                                           ATP-PRTs activated K+.20 reaction
                                                                           shown proceed directly, generation                                                                            covalent intermediate,21 follow sequential ordered
                                                                           kinetic mechanism ATP ï¬?rst substrate bind                                                                            PR-ATP product dissociate.22 Interestingly, ATP-
                                                                           PRT anthranilate-PRT phosphoribosyltrans-
                                                                           ferases (PRTs) described day involved                                                                            nucleoside NAD+/NADP+ metabolism. Common ribosyl
                                                                           acceptors used PRTs orotate, nicotinamide/
                                                                           nicotinate, adenine, hypoxanthine/guanine.
                                                                              regard tertiary quaternary structure,                                                                            types ATP-PRTs. widespread
                                                                           homohexameric form, encountered bacteria, fungi,                                                                            plants, hetero-octameric form, restricted                                                                            bacteria. MtATP-PRT belongs homohexameric class,16
                                                                           Salmonella enterica Escherichia
                                                                           coli.23,24 Crystallographic data suggested MtATP-PRT                                                                            active dimer associates inactive hexamer, L-
                                                                           histidine binding.16 addition, L-histidine-bound hexame-
                                                                           ric form displays major conformational change, twist                                                                            domain III relative domains II. Crystallographic studies
                                                                           revealed L-histidine binds site âˆ¼30 Ã…                                                                            active site, conï¬?rming inhibition allosteric nature.
                                                                           Finally, shown L-histidine held allosteric site
                                                                           interactions carboxyl group Asp218,                                                                            hydroxyl Thr238, backbone amide oxygen                                                                            Ala273.16
                                                                              L-histidineâ€™s imidazole group displays pKa near
                                                                           neutrality (âˆ¼6.0), deï¬?ne ionic form
                                                                           binds inhibits MtATP-PRT. question                                                                            partially answered homologous enzymes S. enterica
                                                                           (SeATP-PRT) Corynebacterium glutamicum (CgATP-
                                                                           PRT).23,25 SeATP-PRT, L-histidine shown inhibit
                                                                           better higher pH values, indicating imidazole ring                                                                            deprotonated. contrast, CgATP-PRT, lower pH values
                                                                           increased potency, suggesting protonated imidazole form
                                                                           inhibits better. Unfortunately, studies used â€œIC50â€? â€œ 
                                                                           activityâ€? surrogates aï¬ƒnity, instead Ki Kd values,
                                                                           making interpretation results diï¬ƒcult. Currently,                                                                            information ionic state L-histidine inhibition                                                                            MtATP-PRT available.
                                                                              work, detailed characterization                                                                            mechanism allosteric inhibition MtATP-PRT L-
                                                                           histidine. use combination steady-state pre-
                                                                           steady-state kinetics, pH studies, 1H NMR spectroscopy,                                                                            gel ï¬?ltration experiments characterize L-histidine
                                                                           allosterically controls MtATP-PRT. results combined
                                                                           structural data available generate new model                                                                            accounts inhibition.
histidine.14,15 M. tuberculosis, hisG gene predicted share operon enzyme pathway, encoded hisE gene. MtATP-PRT proposed potential
                                                                           â–   MATERIALS METHODS
                                                                             Materials. Buï¬€ers purchased Fisher Scientiï¬?c.
target development novel anti-TB agents.16,17 Target            Unless stated, chemicals purchased
                                                                    8028                        dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027âˆ’8038
 Biochemistry                                                                                                                                       Article

Scheme 2



 Sigma-Aldrich. Bakerâ€™s yeast inorganic pyrophosphatase                   pre-steady-state kinetic experiments, larger purchased Sigma-Aldrich. M. tuberculosis inorganic                amounts inorganic pyrophosphatase required, used
pyrophosphatase (Rv3628) produced laboratory (L.                recombinant inorganic pyrophosphatase M. tuberculosis
P. Carvalho, unpublished results). Chromatographic columns                 produced laboratory (L. P. Carvalho, unpublished purchased GE, Ni-NTA resin purchased                     results). EMD. Complete EDTA-Free protease inhibitor                           Gel Filtration. solution oligomeric state MtATP-
purchased Roche. BL21(DE3)pLysS EMD.                         PRT determined using Sephacryl S-200 column    General Methods Equipment. protein concen-                      molecular weight standards (Bio-Rad). Typically, 100 Î¼L tration measured using BCA assay Pierce, using                MtATP-PRT concentrations ranging 0.1 10 mg/mL
bovine serum albumin standard. Protein puriï¬?cation                injected. Protein eluted isocratically 1.5 column
performed using AKTA puriï¬?er 10 (GE Healthcare). SDSâˆ’                   volumes, rate 0.5 mL/min. buï¬€er 20 mM Tris-
PAGE performed PhastSystem (GE Healthcare).                       HCl (pH 8) containing 100 mM NaCl, 2 mM
Spectrophotometry conducted Shimadzu UV-2550                    L-histidine.
spectrophotometer equipped dual-beam optics                        Measurement Enzymatic Activity. Initial velocities Peltier temperature control. Stopped-ï¬‚ow absorb-                forward reaction MtATP-PRT measured ance spectroscopy conducted Applied Photophysics                 following formation PR-ATP (Îµ290 = 3600 Mâˆ’1
SX-20 stopped-ï¬‚ow spectrophotometer, equipped                       cmâˆ’1),26 presence inorganic pyrophosphatase.
circulating water bath. conditions, dead time              Pyrophosphatase essential assay, equilibrium estimated 3 ms. Experiments conducted                    constant lies formation ATP PRPP. typical
mixing equal volumes solutions, containing enzyme               reaction mixture contained 50 mM Tris-HCl (pH 8.5), 7 mM variable substrate L-histidine.          MgCl2, 200 mM KCl, 800 Î¼M ATP, 400 Î¼M PRPP, 3 milliunits
NMR experiments conducted using Varian Inova                        pyrophosphatase, 150 nM MtATP-PRT. activity
spectrometer 14.4 T. assays conducted 25 Â°C.            assays performed 25 Â± 0.2 Â°C.
                                                                              1
concentrations MtATP-PRT reported ï¬?nal                               H NMR Spectroscopy. dimensional spectra L-
                                                                           histidine function pH recorded using excitation
concentrations used, monomer.
                                                                           sculpting27 water suppression. STD spectra recorded
   Plasmid Preparation, Protein Expression, Puriï¬?-
                                                                           interleaved manner range saturation times (0.2âˆ’
cation. Rv2121c gene sequence M. tuberculosis
                                                                           2.0 s 0.2 s intervals) resonance presaturation H37Rv codon adapted E. coli, nucleotide
                                                                           enzyme 0.8 ppm. single oï¬€-resonance control spectrum
sequence synthetically prepared ligated pJ411
                                                                           recorded saturation time 2 s. Water suppression
plasmid (DNA 2.0). DNA sequence conï¬?rmed                            achieved excitation sculpting. Data processing, spectral
sequencing. construct contained noncleavable N-                     subtractions, quantitation performed using VNMRJ
terminal hexahistidine tag facilitate puriï¬?cation. N-               1.1D. physical basis saturation transfer diï¬€erence NMR
terminal hexahistidine tag shown aï¬€ect structure            described 28,29 activity MtATP-PRT.16                                                   Inhibition Studies. determine inhibition constants    MtATP-PRT puriï¬?cation, steps performed               inhibition patterns associated L-histidine, MtATP-PRT
4 Â°C. Frozen BL21(DE3)pLysS (pJ411::hisG) cells                       activity studied presence variable concentrations
thawed ice, lysed sonication, presence                 substrate, ï¬?xed saturating concentrations buï¬€er [20 mM triethanolamine (TEA) (pH 7.8), 300 mM                      substrate metals, ï¬?xed concentrations L-
NaCl, 50 mM imidazole] containing lysozyme                         histidine.
Complete EDTA-free protease inhibitor cocktail. Soluble                       pH Studies. determine eï¬€ect pH protein obtained centrifugation 25000g 30 min.               inhibitory activity L-histidine, MtATP-PRT activity soluble fraction loaded 50 mL Ni-NTA column                 studied presence variable concentrations ATP, ï¬?xed protein separated gradient using buï¬€er B [20 mM               saturating concentrations PRPP metals, ï¬?xed
TEA (pH 7.8), 300 mM NaCl, 500 mM imidazole]. Peak                     concentrations L-histidine, diï¬€erent pHs ranging 6.5
fractions analyzed SDSâˆ’PAGE. Fractions containing                  9.5  HEPES, PIPES, TAPS, CHES buï¬€ers). MtATP-PRT pooled  concentrated, dialyzed                narrow pH range MtATP-PRT, inhibition 20 mM TEA (pH 7.8), stored 50  glycerol âˆ’20 Â°C                data pH 8 9.25 analyzed (TAPS pH 8.0  alternatively, stored âˆ’80 Â°C ï¬‚ash-frozen             8.75 CHES pH 9.0 9.25). pH 8 9.25,
liquid nitrogen. protocol allowed puriï¬?cation                  PRPP concentrations tested shown saturating.
homogeneity 114 mg MtATP-PRT 15 g wet cell                      Pre-Steady-State Kinetics. Photomultiplier voltage pellet. Puriï¬?ed ATP-PRT analyzed electrospray                       zeroed buï¬€er. cell 10 mm path length used
ionization mass spectrometry (ESI-MS) conï¬?rm protein                    experiments. experiments performed 25 Â°C identity (NIMR Mass Spectrometry Facility).                                50 mM Tris-HCl (pH 8.5) containing 150 mM KCl, 10 mM
                                                                    8029                       dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027âˆ’8038
 Biochemistry                                                                                                                                          Article

MgCl2, 1.5 mM PRPP, 60 Î¼M pyrophosphatase, 10 Î¼M                                       âŽ¡                                                    âŽ¤
MtATP-PRT. Higher concentrations substrates metals                                 {
                                                                                 = max âŽ£E + S + Kdapp âˆ’              (E + S + Kdapp)2 âˆ’ 4ES âŽ¦ used, precipitation. Typically, 10 progress
curves 1000 points averaged data                           /(2E)}
                                                                                                                                                            (8)
ï¬?t. Rates amplitudes obtained ï¬?tting average burst equation (eq 7). Mixing achieved rapid                      Amax amplitude maximum, E concentration
combination 60 Î¼L syringe. eï¬€ect                         enzyme, S total concentration ATP, Kapp
                                                                                                                                      d increasing concentrations ATP  0.025 4 mM) L-                 apparent dissociation constant ATP. Similarly, histidine  5 80 Î¼M) rate reaction                  dependence kobs ATP concentration conditions
measured monitoring conversion ATP PR-ATP,                   substrate enzyme concentrations comparable observing increase absorbance 290 nm.                              ï¬?t eq 9
   Data Analysis. Steady-state NMR data ï¬?t using
                                                                                                âŽ¡ nonlinear, squares, curve-ï¬?tting programs Sigma-
Plot Windows, version 11.0. Pre-steady-state data ï¬?t
                                                                                             {
                                                                                 kobs = k burst âŽ£E + S + Kdapp

using KinTek Global Kinetic Explorer,30,31 version 3.0.                                                             âŽ¤
Individual saturation curves ï¬?t eq 1
                                                                                        âˆ’    (E + S + Kdapp)2 âˆ’ 4ES âŽ¦ /(2E)              }                  (9)

   v = VA / + K )                                            (1)           kburst maximal burst rate. dependence                                                                              burst amplitude L-histidine concentration ï¬?t V maximal velocity, substrate metal
concentration, K Michaelis constant substrate                 =  0Kd)/(Kd +  )                                                    (10)
(Km) constant metal (Kact). Individual saturation                 A0 maximal amplitude  absence L-
curves showing substrate inhibition pattern ï¬?t eq 2                  histidine)   concentration L-histidine.                                                                              dependence kobs concentration L-histidine    v = VA /[K act + 1 + /K iapp)]                          (2)           described step binding mechanism, according eq 11 Kapp
          apparent inhibition constant  Inhibition                kobs = kon  + koff                                                      (11)
data, recorded saturating concentrations ATP, PRPP,
Mg2+, K+ variable concentration L-histidine, ï¬?t              kon second-order association rate constant koff eq 3                                                                      unimolecular dissociation rate constant.

   v = v0/[1 +  /IC50)nH ]                                   (3)           â–     RESULTS
                                                                                MtATP-PRT Puriï¬?cation. hisG (rv2121) gene v0 uninhibited velocity, L-histidine                   sequence M. tuberculosis H37Rv codon-adapted concentration, IC50 concentration L-histidine necessary            E. coli chemically synthesized ligated pJ411, 50  inhibition, nH Hill number. Inhibition                nucleotide sequence conï¬?rmed (DNA 2.0); 7.6 mg
data showing linear, noncompetitive, uncompetitive patterns               MtATP-PRT puriï¬?ed gram BL21(DE3)pLysS double-reciprocal plots ï¬?t eqs 4 5                            (pJ411::hisG), using single Ni-NTA chromatographic step.
   v = VA /[K (1 + /K  + 1 + /K ii)]                  (4)           Puriï¬?ed MtATP-PRT subjected ESI-MS identi-
                                                                             ï¬?cation. puriï¬?ed protein exhibited molecular mass                                                                              31,515.1 Da, experimental error    v = VA /[K + 1 + /K ii)]                                (5)           calculated molecular mass 31515.6 Da. result conï¬?rms
                                                                             identity enzyme used following experiments. Kis Kii slope intercept inhibition
                                                                                Oligomeric State MtATP-PRT. determined constants, respectively. NMR chemical shift data showing                                                                              apparent solution molecular mass MtATP-PRT using gel
single titration event ï¬?t variation Hendersonâˆ’
                                                                             ï¬?ltration, Sephadex S200 column. Figure 1 depicts
Hasselbalch equation32
                                                                             representative chromatograms obtained, showing    Î´ = (Î´acid + Î´ base10 pH âˆ’ pKa)/(1 + 10 pH âˆ’ pKa)                         mycobacterial enzyme behaves single species solution,
                                                               (6)
                                                                             apparent molecular mass âˆ¼180 kDa. molecular Î´ instantaneous chemical shift parts million,            mass consistent hexameric form. repetition Î´acid chemical shift protonated form, Î´base             experiment lower concentrations protein yields chemical shift deprotonated form, pH                           result, indicating MtATP-PRT does display antilogarithm concentration protons, pKa                concentration-dependent change oligomeric state acid dissociation constant group titrated. Pre-                protein concentrations ranging 0.1 10 mg/mL.
steady-state burst kinetic data ï¬?t eq 7                              Repetition experiment presence 2 mM L-
                                                                             histidine (Figure 1) showed overall result. Repetition
   Yt = eâˆ’kobst + vt + C                                     (7)           experiment presence ATP  ï¬?rst substrate                                                                              bind ATP-PRTs) did yield observable change Yt observed signal time t, amplitude             apparent molecular mass (data shown). results transient, kobs observed burst rate transient, v          indicate MtATP-PRT hexamer solution linear rate, C oï¬€set linear phase.              oligomeric state inï¬‚uenced allosteric inhibitor dependence burst amplitude ATP concentration                       ATP, ï¬?rst substrate. conditions substrate enzyme concentration                       Steady-State Kinetics Inhibition Studies. MtATP- comparable described eq 833                                       PRT displays Michaelisâˆ’Menten kinetics substrates
                                                                      8030                        dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027âˆ’8038
 Biochemistry                                                                                                                                                      Article

                                                                                   product, PR-ATP, potent inhibitor ATP-PRTs.34
                                                                                   Interestingly, MtATP-PRT displays low activity neutral
                                                                                   acidic pH.  lowest pH used kinetic
                                                                                   studies 8.0. activity observed presence                                                                                    metal-chelating agent EDTA, indicating Mg2+ essential
                                                                                   activity rapidly dissociating enzyme (data
                                                                                   shown). Addition thiol reducing agent DTT did                                                                                    alter time course (data shown), indicating                                                                                    enzyme preparation did contain oxidized cysteine residues
                                                                                   disulï¬ bonds inhibit activity.
                                                                                      Apparent Km values obtained ATP (263 Â± 63 Î¼M)
                                                                                   presence saturating concentrations PRPP                                                                                    MgCl2 200 mM KCl (Figure 2, panel) PRPP
                                                                                   (49 Â± 6 Î¼M) presence saturating levels ATP,
                                                                                   MgCl2, KCl (Figure 2, middle panel). observed Figure 1. MtATP-PRT hexameric solution presence                   SeATP-PRT,22 high concentrations MgCl2 led inhibition
absence L-histidine. Gel ï¬?ltration experiment illustrating lack          MtATP-PRT. Apparent Kact Ki values obtained change oligomeric state MtATP-PRT. Solid dashed lines                MgCl2 (1.9 Â± 0.6 23.3 Â± 8.6 mM, respectively) representative chromatographic traces MtATP-PRT (100 Î¼g)                    presence saturating concentrations substrates analyzed Sephacryl S200 absence presence 2 mM                 200 mM KCl (data shown). eï¬€ect K+ rate L-histidine, respectively. experiments performed 20 mM
Tris-HCl (pH 8) containing 100 mM NaCl. Results representative
                                                                                   MtATP-PRT saturable;  performed independent experiments.                                                   experiments 200 mM KCl (data shown). Steady-state
                                                                                   data summarized Table 1.

(Figure 2). Time courses linear minutes (data                   Table 1. Steady-State Pre-Steady-State Kinetic shown), consistent previous observations                    Parameters MtATP-PRTa
                                                                                              parameter                            best ï¬?t                   equation
                                                                                        Vmax (sâˆ’1)                              0.31 Â± 0.01                      1
                                                                                        Km,ATP (Î¼M)                             263 Â± 63                         1
                                                                                        Km,PRPP (Î¼M)                            49 Â± 6                           1
                                                                                        Kact,Mg2+ (Î¼M)                          1900 Â± 600                       2
                                                                                        Ki,Mg2+ (Î¼M)                            23000 Â± 900                      2
                                                                                        IC50,Lâ€‘histidine (Î¼M)                   33 Â± 3                           3
                                                                                        Amax (Î¼M)                               7.8 Â± 0.3                        8
                                                                                        Kapp
                                                                                          d,ATP (Î¼M)                            47.2 Â± 10.3                      8
                                                                                        Kburst (sâˆ’1)                            0.67 Â± 0.02                      9
                                                                                        Kd,Lâ€‘histidine (Î¼M)                     27.9 Â± 3.2                       10
                                                                                        kon,Lâ€‘histidine (Mâˆ’1 sâˆ’1)               4885 Â± 717                       11
                                                                                        koff,Lâ€‘histidine (sâˆ’1)                  0.95 Â± 0.03                      11
                                                                                                                                                                        Assays performed 50 mM buï¬€er, containing MgCl2 KCl,                                                                                    speciï¬?ed values, 25 Â°C. Materials Methods buï¬€ers
                                                                                   concentrations substrates, metals, L-histidine.

                                                                                      conï¬?rmed inhibition MtATP-PRT L-
                                                                                   histidine determining IC50. seen Figure 2
                                                                                    panel), preparation MtATP-PRT readily
                                                                                   inhibited L-histidine. experimental conditions,                                                                                    IC50 obtained L-histidine 33.3 Â± 3.5 Î¼M Hill
                                                                                   number 1.5 (Table 1). obtain inhibition constants (Ki),
                                                                                   independent concentration enzyme,
Figure 2. Steady-state kinetics MtATP-PRT inhibition L-              substrates, metal ions used,35 deï¬?ne nature histidine. middle panels saturation curves                inhibition, performed single inhibition studies ï¬?xed
ATP (â—?) PRPP (â—‹), respectively. experiments                         saturating concentration substrate ï¬?xed variable
performed 25 Â°C, 50 mM Tris-HCl (pH 8.5) containing 7 mM                     concentrations second substrate. Inhibition L-histidine
MgCl2 200 mM KCl. ATP concentration varied,                       versus PRPP linear noncompetitive (Figure 3), PRPP concentration 0.8 mM. PRPP concentration                     set lines intersecting left Y-axis double- varied, ATP concentration 1.6 mM. panel
shows inhibition  single substrate concentration) MtATP-
                                                                                   reciprocal plot, Kii value 23.5 Â± 6.5 Î¼M Kis value
PRT L-histidine (â—?). experiment performed 25 Â°C,                 25.7 Â± 12.8 Î¼M. Kii Kis values identical 50 mM Tris-HCl (pH 8.5) containing 7 mM MgCl2, 200 mM KCl, 1.6                     experimental error, L-histidine appears aï¬ƒnity
mM ATP, 0.8 mM PRPP. Points data lines best ï¬?t eq 1                 enzyme presence absence PRPP.  middle panels) eq 2  panel). Results                       ATP concentration varied, L-histidine inhibition linear
representative independent experiments.                                     uncompetitive (Figure 4), set parallel lines                                                                             8031                              dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027âˆ’8038
 Biochemistry                                                                                                                                            Article




Figure 3. Inhibition MtATP-PRT L-histidine vs PRPP.   Double-reciprocal plot illustrating linear noncompetitive inhibition pattern
obtained varying concentration L-histidine ï¬?xed variable concentrations PRPP ï¬?xed saturating concentrations ATP, Mg2+, K+. Data obtained 50 mM Tris-HCl (pH 8.5) 25 Â°C. Results representative independent experiments. Points data
obtained 0 (â—?), 15 (â—‹), 30 (â– ), 45 Î¼M L-histidine (â–¡), error bars indicate standard deviation. Lines best ï¬?t entire
data set eq 3. (B) Replot intercept data shown panel  , showing linear dependence inhibitor concentration. Replot slope data shown panel  , showing linear dependence inhibitor concentration. Points data, line linear
regression data.




Figure 4. Inhibition MtATP-PRT L-histidine vs ATP.   Double-reciprocal plot illustrating linear uncompetitive inhibition pattern
obtained varying concentration L-histidine ï¬?xed variable concentrations ATP ï¬?xed saturating concentrations PRPP, Mg2+, K+. Data obtained 50 mM Tris-HCl (pH 8.5) 25 Â°C. result representative independent experiments. Points data
obtained 0 (â—?), 15 (â—‹), 30 (â– ), 45 Î¼M L-histidine (â–¡), error bars indicate standard deviation. Lines best ï¬?t entire
data set eq 4. (B) Replot intercept data shown panel  showing linear dependence inhibitor concentration. Points data, line linear regression data.

double-reciprocal plot, Kii value 27.9 Â± 1.9 Î¼M.                STD experiments, recorded spectra L-histidine result indicates binding ATP essential inhibition            function pH determine ionization states L-histidine. Inhibition data summarized Table 2.                        experimental conditions pH-dependent changes    Ionic States L-Histidine Interaction                            chemical shifts sets protons L-histidine
MtATP-PRT. deï¬?ne ionic state L-histidine bound                       (Figure 5A). chemical shift protons inï¬‚uenced MtATP-PRT, ï¬?rst employed equilibrium ï¬‚uorescence                         pH shown Figure 5B. Taken  results
measurements. Unfortunately, binding L-histidine                       indicate experimental conditions protons CÎ´2-
modestly alters intrinsic tryptophan ï¬‚uorescence spectrum                  H, CÎµ1-H, CÎ±-H coupled report MtATP-PRT (data shown), precluding quantitative                         ionization imidazole ring. hand, protons
analysis. alternative ï¬‚uorescence, employed 1H                     CÎ²-H2 inform ionization Î±-amino group. Data
NMR characterize interaction. reasoned STD-                    shown Figure 5C Table 3 indicate L-histidine bound
NMRa constitute simple eï¬ƒcient way                              MtATP-PRT subjected saturation transfer, monitoring ligand binding diï¬€erent pH values.                    expected, process inï¬‚uenced pH. Speciï¬?cally,
                                                                        8032                        dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027âˆ’8038
 Biochemistry                                                                                                                                             Article

Table 2. Steady-State Inhibition Constants MtATP-PRT L-Histidinea
             varied       inhibition
    pH     substrateb      patternc       Kii (Î¼M)          Kis (Î¼M)
    8.50     PRPP            NC           23.5   Â±   6.5   25.7 Â± 12.8
    8.50     ATP             UC           27.9   Â±   1.9   âˆ’
    8.00     ATP             UC            4.0   Â±   0.4   âˆ’
    8.25     ATP             UC            7.9   Â±   1.5   âˆ’
    8.50     ATP             UC           28.3   Â±   2.1   âˆ’
    8.75     ATP             UC           26.8   Â±   1.5   âˆ’
    9.00     ATP             UC           50.4   Â±   5.5   âˆ’
    9.25     ATP             UC          109.4   Â±   6.8   âˆ’  Assays performed 50 mM buï¬€er containing 7 mM MgCl2 200
mM KCl, speciï¬?ed pH values, 25 Â°C. Materials Methods buï¬€ers pH. bThe concentrations cosubstrates held ï¬?xed (0.8 mM PRPP 1.6 mM ATP). cNC,
noncompetitive; UC, uncompetitive.

saturation transfer neglible lower pH values (<7.5) maximal high pH values (âˆ¼9), indicating neutral
imidazole deprotonated Î±-amino group favor binding. aliphatic protons appear pick saturation (Table 3),
indicating looser contact protein, compared imidazole protons.
   pHâˆ’Rate Studies. investigate eï¬€ect pH allosteric inhibition, determined Kii values L-
histidine, varying ATP concentration ï¬?xed saturating
concentration PRPP, various pH values. Figure 6 Table 2, L-histidine inhibition dependent pH, surprisingly, pH dependence inhibition opposite observed binding (inhibition weaker higher pH values). pH range 8âˆ’9.25, group titrated Î±-amino group L-histidine,  likely observing direct eï¬€ect protonation
state inhibition. Unfortunately, low activity MtATP-PRT neutral acidic pH values, determine Kii values pH 8.0.  pKa values derived analysis, slope 1 obtained. result suggests deprotonation Î±-
amino group decreases inhibition potency.
   Pre-Steady-State Inhibition Studies. investigate elementary steps catalytic cycle directly
aï¬€ected L-histidine, studied inhibition MtATP-PRT
using pre-steady-state kinetics (Table 1).  characterized kinetics absence inhibitor, determine                  Figure 5. Ionic states STD-NMR spectroscopy studies L-
chemistry rate-limiting. Figure 7,                   histidine binding MtATP-PRT.   1H NMR spectrum L-
multiple-turnover conditions progress curve MtATP-                       histidine 10 mM, 50 mM KPi (pH 8). asterisk indicates                                                                                 water signal. (B) Chemical shift dependence pH L-histidine. PRT displays burst kinetics. described single-
                                                                                panel shows data ring protons, CÎ´2-H (â—‹) CÎµ1-H (â—?).
exponential increase followed steady-state phase (eq 7).                   panel shows data aliphatic protons, CÎ±-H (â–¡) Burst kinetics diagnostic chemistry faster                     CÎ²-H (â– ). Experiments performed 50 mM sodium phosphate
subsequent steps.36,37 particular case, product (PR-ATP)                buï¬€er indicated pH values, presence 0.4 mM L-histidine.
formation directly observed,  buildup                     Symbols data, solid lines ï¬?ts eq 5. (C) pH
product indicates slower steps chemical step. Burst                   dependence STD-NMR L-histidine 30 Î¼M MtATP-PRT.
kinetics studied varying concentration ATP.                    Aromatic resonances (CÎ´2 CÎµ1) shown. Figure 8, quadratic dependence burst amplitude ATP concentration exper-                         mentioning  conditions, Y intercept imental conditions (Figure 8B, panel) amplitude                     plot burst dependence ATP concentration zero,
maximum 7.8 Â± 0.3 Î¼M (Table 3). value close                  indicating slow ATP dissociation. actual concentration active sites used (10 Î¼M),                             probed eï¬€ect L-histidine, ï¬?xed saturating
suggesting MtATP-PRT active catalysis.b                     ATP concentration. diï¬€erent eï¬€ects observed observed dependence kobs ATP concentration                      multiple-turnover conditions. marked eï¬€ect burst ï¬?t quadratic equation (Figure 8B, panel),                   amplitude apparent increasing concentrations L-
giving maximal kburst 0.67 Â± 0.02 sâˆ’1 (Table 1). worth               histidine (Figure 9A,B). decrease burst amplitude
                                                                         8033                        dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027âˆ’8038
 Biochemistry                                                                                                                                                    Article

Table 3. Saturation Transfer Data L-Histidine MtATP-PRTa
                          saturation transfer L-histidine protons
    pH           CÎ±-H            CÎ²-H2            CÎ´2-H            CÎµ1-H
    5.5            0               0                0                    0
    6.0            0               0                0                    0
    6.5            0               0                0                    0
    7.5            0               0                0                    0
    8.0            0               0               36.9                 40.4
    8.5            0               0               81.6                 88.2
    9.0            0               0              100                  100   Assays performed 50 mM sodium phosphate buï¬€er speciï¬?ed
pH values 25 Â°C, containing 0.6 mM L-histidine 30 Î¼M HisG.




                                                                                      Figure 8. Pre-steady-state kinetics MtATP-PRT varying ATP
                                                                                      concentration.   Representative traces MtATP-PRT reaction
Figure 6. pH dependence MtATP-PRT inhibition L-histidine. Kii
                                                                                      multiple-turnover conditions obtained diï¬€erent concen-
values obtained varying L-histidine concentration various
                                                                                      trations ATP ï¬?xed saturating concentrations PRPP ï¬?xed concentrations ATP ï¬?xed saturating concentrations                                                                                       metals. Gray lines represent data black lines best ï¬?t eq
PRPP, MgCl2, KCl. experiments performed 25 Â°C.
                                                                                      6. Data averages 10 traces. (B) Plot burst amplitude vs
Symbols values obtained speciï¬?ed pH values ï¬?tting data
                                                                                      ATP concentration   plot kobs vs ATP concentration eq 4; error bars represent standard error obtained ï¬?t                                                                                        . Symbols represent data solid lines best ï¬?t eqs 8
eq 4, solid line linear regression data.
                                                                                      9 burst amplitude burst rate dependencies, respectively.
                                                                                      Reactions conducted 50 mM Tris-HCl (pH 8.5), 150 mM
                                                                                      KCl, 10 mM MgCl2, 1.5 mM PRPP, 10 Î¼M MtATP-PRT, 25
                                                                                      Â°C. Results representative independent experiments.

                                                                                      chemical steps characterized decrease                                                                                       steady-state rate burst rate, respectively. Kd value                                                                                       27.9 Â± 3.2 Î¼M obtained ï¬?tting data eq 10,                                                                                       good agreement Ki value obtained steady-state
                                                                                      kinetics. addition, linear decrease kobs observed (Figure
                                                                                      9C,D).

                                                                                      â–     DISCUSSION
                                                                                         Oligomeric State MtATP-PRT. gel ï¬?ltration
                                                                                      experiments indicate MtATP-PRT mainly hexameric                                                                                       absence ligands presence L-histidine ATP,
                                                                                      pH 8. result appears contrast                                                                                       results obtained Cho colleagues,16 dimerâˆ’hexamer
Figure 7. Stopped-ï¬‚ow absorbance time course MtATP-PRT                         equilibrium, believe explained reaction. Representative trace MtATP-PRT progress curve (10
                                                                                      experimental conditions used. worth mentioning Î¼M enzyme), multiple-turnover conditions, obtained saturating concentrations ATP PRPP, 50 mM Tris-HCl                          shift oligomeric state observed hexameric
(pH 8.5) 25 Â°C. gray line shows data, black line                       homologous enzyme S. enterica.20,23 interpretation represents best ï¬?t burst equation (eq 7). inset shows                  results lower pH values lead dissociation residuals ï¬?t burst equation.                                      MtATP-PRT dimers, observed Cho et al. 
                                                                                      evidence dimer represents kinetically
                                                                                      competent form MtATP-PRT, activity decreases
indicates L-histidine aï¬€ects MtATP-PRT largely                                drastically pH drops 8. Similar results trapping inactive complex. Slower product release                         recently reported ATP-PRT C. glutamicum.                                                                                8034                         dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027âˆ’8038
 Biochemistry                                                                                                                                            Article

                                                                                conformational changes invoked explain                                                                                 allosteric inhibition.
                                                                                   Inhibition MtATP-PRT L-Histidine. Steady-state
                                                                                kinetic analysis indicates L-histidine inhibition versus PRPP
                                                                                linear noncompetitive, Kis = Kii. equality                                                                                 inhibition constants indicates L-histidine                                                                                 aï¬ƒnity ATP-bound ATP-PRPP-bound enzyme
                                                                                forms. L-Histidine inhibition versus ATP linear                                                                                 uncompetitive, indicating L-histidine binds MtATP-
                                                                                PRT ATP present enzyme active site.                                                                                 results fully consistent allosteric inhibition
                                                                                proposed basis structure. addition,
                                                                                uncompetitive inhibition versus ATP agreement                                                                                 L-histidineâˆ’AMP ternary complex structure determined X-
                                                                                ray crystallography.16
                                                                                   Pre-steady-state kinetic analysis enzyme inhibition                                                                                 powerful approach determining step steps                                                                                 aï¬€ected given inhibitor, applied study                                                                                 number systems, including DNA polymerase Î³,38 HIV-1
                                                                                reverse transcriptase,39 D-3-phosphoglycerate dehydrogenase,40
                                                                                BACE.41 gather information L-
                                                                                histidine inhibits MtATP-PRT, performed pre-steady-state
                                                                                kinetic studies, using stopped-ï¬‚ow absorbance, monitoring PR-
                                                                                ATP formation. L-Histidine inhibition pre-steady-state
                                                                                conditions complex, aï¬€ecting multiple steps. dominant
                                                                                eï¬€ect observed decrease amplitude burst,
Figure 9. Pre-steady-state kinetics MtATP-PRT inhibition L-
                                                                                decrease burst steady-state rates. histidine.   Representative traces MtATP-PRT reaction            decrease burst amplitude indicates L-histidine inhibits
pre-steady-state conditions various L-histidine concentrations,          MtATP-PRT trapping form catalytic ï¬?xed saturating concentrations ATP, PRPP, metals. Gray             inactive, severely slowing chemistry product
lines represent data black lines best ï¬?ts eq 6. Data             release. basis results sequential ordered
averages 10 traces. (B) Plot burst amplitude vs L-histidine           kinetic mechanismc previously proposed ATP-PRTs, concentration   plot kobs vs L-histidine concentration               inhibition using Scheme 3. Burton et al. elegantly
 . Symbols represent data solid lines best ï¬?ts eqs 10             demonstrated similar mechanism feedback allosteric 11 burst amplitude burst rate dependencies, respectively.
Reactions conducted 50 mM Tris-HCl (pH 8.5), 150 mM
                                                                                inhibition E. coli D-3-phosphoglycerate dehydrogenase
KCl, 10 mM MgCl2, 1.5 mM PRPP, 4 mM ATP, 10 Î¼M MtATP-                       (PGDH) L-serine.40 important stress MtATP-
PRT, 25 Â°C. Results representative independent                    PRT PGDH structurally unrelated enzymes, experiments.                                                                    catalyze diï¬€erent types chemistry distinct
                                                                                substrates.  conservation allosteric
                                                                                mechanism, e.g., sequestration enzymeâˆ’substrateâˆ’ dimer present gel ï¬?ltration  pH 7.2),                   inhibitor complex nonproductive form, appears CgATP-PRT loses activity pH 8.25                               successful case convergent evolution.
   dimerâˆ’hexamer equilibrium does account                       basis steady-state data, extent L-histidine
allosteric inhibition, mechanism envisioned.               inhibition maximal saturating ATP concentrations noteworthy mention Cho colleagues16 observed                   (uncompetitive kinetic pattern) independent large domain shift, domain III, dimeric form                          concentration PRPP [noncompetitive kinetic pattern (Kii =
compared hexameric form. dimeric form                    Kis)]. Taken  results steady-state pre-steady- present experimental conditions, domain                    state experiments indicate kâˆ’6/k6 kâˆ’7/k7 ratios
shift place, generating alternative hexamer,                (Scheme 3) similar, Eâˆ’ATPâˆ’ inhibited. Regardless conforma-                  histidine Eâˆ’ATPâˆ’PRPPâˆ’histidine complexes tional change responsible L-histidine inhibition,                inactive forms MtATP-PRT. structural basis propose MtATP-PRT functional hexamer                           eï¬€ect deï¬?ned lack structural

Scheme 3




                                                                         8035                       dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027âˆ’8038
 Biochemistry                                                                                                                                            Article

information regarding complexes MtATP-PRT                       0.4 40 Î¼M, correlate maximal variation
substrates products, L-histidine.                          expected L-histidine M. tuberculosis.
    Ionic States L-Histidine Bound ATP-PRT.                             ATP-PRT characterized regard
deï¬?nition ionic state L-histidine best binds             inhibition constants. Comparison value reported best inhibits MtATP-PRT essential step                        Lactococcus lactis ATP-PRT indicates L-histidine levels
molecular description inhibition, paves way              ï¬‚uctuate 10-fold bacteria, Ki 81 Î¼M rational approach target site. ï¬?rst analyzed                    determined, pH 8.42 S. enterica serovar Typhimurium,
binding, using STD-NMR. pH dependence STD-                          intracellular concentration L-histidine shown vary
NMR clearly demonstrates L-histidine binds better                      15 100 Î¼M, depending growth
MtATP-PRT higher pH values. speciï¬?cally, deproto-                      conditions.15 basis values, concentration
nation Î±-amino group L-histidine increases extent                L-histidine M. tuberculosis range saturation transfer, correlates increased level               Salmonella Lactococcus. binding. basis identity residues involved                 Chemical Mechanism. observations L-histidine binding, Asp218, Thr238, Ala273,                         regarding chemical mechanism MtATP-PRT. 
tentatively assign eï¬€ect titration Î±-amino group                MtATP-PRT displays unusual pH dependence, L-histidine (pKa âˆ¼ 9). result likely              observed homologous enzymes.25 MtATP-
physiological importance, cytoplasm reach pH 9,                PRT inactive pH â‰¤7, active neutral alkaline pH hints potential mechanism preparing L-histidine                 values 9.5. basis alkaline pH dependence analogues bind tightly MtATP-PRT.                                      unknown, caused highly basic active site,
   kinetic results demonstrate L-histidine inhibition              bind phosphates substrates, stronger (lower Ki values) near pH 8. opposite result              missing protein partner, alter obtained binding indicates form L-histidine               acidic pH. best inhibits MtATP-PRT diï¬€erent form L-                      Second, multiple-turnover experiments showed burst histidine best binds  IC50 measurements L-                 product formation, indicating step chemistry histidine inhibition diï¬€erent pH values performed                 partially rate-limiting MtATP-PRT. Unfortunately, ATP-PRTs, ï¬?rst report pH                         studies ATP-PRTs pre-steady-state
dependence Ki L-histidine ATP-PRT. Bearing                       conditions, slow product release shown mind IC50 values misleading                  ubiquitous trait phosphoribosyltransferases. account concentration enzyme, substrates                   example, quinolinate phosphoribosyltransferase saturation, inhibition type, , note inhibitory           shown display burst kinetics, indicating chemistry behavior seen MtATP-PRT appears follow                        rate-limiting relatively slow (kobs = kcat = 0.4 sâˆ’1).43 trend observed homologous enzymes S. enterica                    contrast, nicotinate phosphoribosyltransferase displayed burst C. glutamicum.23,25 Speciï¬?cally, higher pH values decrease                 kinetics, indicating fast chemistry (kobs â‰¥ 500 sâˆ’1) slow inhibitory eï¬€ect L-histidine, appears                  product release (kcat = 1.2 sâˆ’1).44
correlates pKa Î±-amino group. emphasize                        Summary. Results presented indicate active L- ionizable groups responsible transmission                histidine-inhibited MtATP-PRT hexameric solution. L- inhibitory signal allosteric site active site          Histidine inhibition noncompetitive versus PRPP certainly important, unfortunately,                     uncompetitive versus ATP. Inhibition MtATP-PRT L-
observed narrow pH range                          histidine strongly inï¬‚uenced pH, reaching higher potency
employed study catalysis inhibition.                                    closer physiological pH. Binding L-histidine displays    Finally, important explain â€œreverse                      opposite pH dependence observed inhibition, indicating
protonationâ€? behavior likely unique L-histidine                 deprotonation Î±-amino group increases level MtATP-PRT. Usually, allosteric regulation enzymes                    binding decreases level inhibition.  L-
studied analysis binding inhibition, rarely             histidine binds inhibits MtATP-PRT neutral pH dependence investigated.                          imidazole ionized Î±-amino Î±-carboxyl groups. Pre-
assumption dissociation constant (Kd) inhibition                  steady-state kinetic studies revealed step chemistry
constant (Ki) allosteric inhibitors identical              partially rate-limiting L-histidine exerts inhibition
oversimpliï¬?cation. likely case dealing                  decreasing catalytically active MtATP-PRT inhibitors allosteric sites contain groups               (Scheme 3). ionization constants near neutrality. allosteric
inhibitors discovered characterized, examples likely 
                                                                               â–    AUTHOR INFORMATION
                                                                               Corresponding Author
    L-Histidine Biosynthesis M. tuberculosis.                                                                                *MRC National Institute Medical Research, Ridgeway,
conclusions regarding L-histidine levels drawn                     Hill, London NW7 1AA, U.K. Telephone: +44 (0)20 8816 studies. Assuming ATP saturating concentration                  2358. Fax: +44 (0)20 8816 2730. E-mail: luiz.pedro@nimr.mrc. cell,d half-maximal inhibition 4 Î¼M                  ac.uk.
L -histidine, pH 8. indicates physiological
concentrations L-histidine varying                      Funding
value able feedback control pathway. Speciï¬?cally,                 Work L.P.S.d.C. laboratory funded MRC
concentrations â‰¤0.4 Î¼M make MtATP-PRT                          (MC_UP_A253_1111). S.P. J.P.P. recipients active, conversely, concentrations L-histidine â‰¥40 Î¼M                Erasmus Fellowships, European Commission. inhibit MtATP-PRT shut L-histidine                    Notes
biosynthesis M. tuberculosis.  range,                authors declare competing ï¬?nancial 
                                                                        8036                        dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027âˆ’8038
 Biochemistry

â– 
                                                                                                                                                             Article

    ACKNOWLEDGMENTS                                                                 (4) Cook, P. F., Cleland, W. W. (2007) Enzyme Kinetics                                                                                   Mechanism, Garland Science Publishing, New York. thank Dr. Steve Howell ESI-MS analysis MtATP-                             (5) Bearer, C. F., Neet, K. E. (1978) Threonine inhibition PRT NIMRâ€™s Large Scale Laboratory E. coli growth.                      aspartokinase-homoserine dehydrogenase Escherichia coli. slow
thank Drs. Clarissa M. Czekster Rafael G. da Silva                        transient cooperativity inhibition aspartokinase activity.
thoughtful discussions. NMR spectra recorded                      Biochemistry 17, 3523âˆ’3530.
MRC Biomedical NMR Centre, NIMR, Hill (funded                               (6) Carvalho, L. P., Argyrou, , Blanchard, J. S. (2005) Slow-
MRC Grant Aid U117533887).                                                     onset feedback inhibition: Inhibition Mycobacterium tuberculosis Î±-


â– 
                                                                                  isopropylmalate synthase L-leucine. J.  Chem. Soc. 127, 10004âˆ’
    ABBREVIATIONS                                                                 10005.
                                                                                    (7) Edfeldt, F. N., Folmer, R. H., Breeze,  L. (2011) Fragment
ATP-PRT, ATP phosphoribosyltransferase; PR-ATP, 1-(5-                             screening predict druggability (ligandability) lead discovery
phospho-Î±-D-ribosyl)-ATP; PPi, inorganic pyrophosphate;                           success. Drug Discovery Today 16, 284âˆ’287.
PRPP, 5-phospho-Î±-D-ribosyl pyrophosphate; SDSâˆ’PAGE,                                (8) Surade, S., Blundell, T. L. (2012) Structural biology drug
sodium dodecyl sulfateâˆ’polyacrylamide gel electrophoresis;                        discovery difficult targets: limits ligandability. Chem. Biol. 19,
TEA, triethanolamine; BCA, bicinchoninic acid; BSA, bovine                        42âˆ’50.
serum albumin; Tris, tris(hydroxymethyl)aminomethane; ESI-                          (9) Fenton,  W. (2012) Identification allosteric-activating drug
                                                                                  leads human liver pyruvate kinase. Methods Mol. Biol. 796, 369âˆ’
MS, electrospray ionization mass spectrometry; HEPES, 4-(2-
                                                                                  382.
hydroxyethyl)piperazine-1-ethanesulfonic acid; NMR, nuclear                         (10) Luo, L., Parrish, C. , Nevins, N., McNulty, D. E., Chaudhari,
magnetic resonance; STD, saturation transfer diï¬€erence;                            M., Carson, J. D., Sudakin, V., Shaw,  N., Lehr, R., Zhao, H.,
PIPES, 1,4-piperazinediethanesulfonic acid; TAPS, N-[tris-                        Sweitzer, S., Lad, L., Wood, K. W., Sakowicz, R., Annan, R. S., Huang,
(hydroxymethyl)methyl]-3-aminopropanesulfonic acid; CHES,                         P. S., Jackson, J. R., Dhanak, D., Copeland, R. , Auger, K. R.
2-(cyclohexylamino)ethanesulfonic acid.                                           (2007) ATP-competitive inhibitors mitotic kinesin KSP 
â– 
                                                                                  function allosteric mechanism. Nat. Chem. Biol. 3, 722âˆ’726.
     ADDITIONAL NOTES                                                               (11) Liu, S., Chang, J. S., Herberg, J. T., Horng, M. M., Tomich, P. K.,                                                                                 Lin,  H., Marotti, K. R. (2006) Allosteric inhibition   Saturation transfer diï¬€erence NMR (STD-NMR) 1H                             Staphylococcus aureus D-alanine:D-alanine ligase revealed crystallo-
NMR method developed monitoring interaction                            graphic studies. Proc. Natl. Acad. Sci. U.S  103, 15178âˆ’15183.
small molecules proteins, resonance assign-                        (12) Ceccarelli, D. F., Tang, X., Pelletier, B., Orlicky, S., Xie, W.,
ments protein necessary.28,29 method, ï¬?rst                 Plantevin, V., Neculai, D., Chou, Y. C., Ogunjimi, , Al-Hakim, ,
spectrum protein ligand obtained, followed                        Varelas, X., Koszela, J., Wasney, G. , Vedadi, M., Dhe-Paganon, S.,
second spectrum radiofrequency ablated                            Cox, S., Xu, S., Lopez-Girona, , Mercurio, F., Wrana, J., Durocher,
resonances protein spin diï¬€usion                           D., Meloche, S., Webb, D. R., Tyers, M., Sicheri, F. (2011) bound ligand (saturation transfer). ligand                           allosteric inhibitor human Cdc34 ubiquitin-conjugating enzyme.
equilibrium bound free states, signals                    Cell 145, 1075âˆ’1087.
                                                                                    (13) Sousa, M. C., Kessler, B. M., Overkleeft, H. S., McKay, D. B.
perturbed, ones bound ligand.                          (2002) Crystal structure HslUV complexed vinyl sulfone spectra obtained, subtracted,                          inhibitor: corroboration proposed mechanism allosteric
resulting diï¬€erence spectrum reveals resonances                      activation HslV HslU. J. Mol. Biol. 318, 779âˆ’785.
ligand aï¬€ected, indicating direct contact protein.                       (14) Ames, B. N., Martin, R. G., Garry, B. J. (1961) step
b
  amplitude burst observed pre-steady-state                      histidine biosynthesis. J. Biol. Chem. 236, 2019âˆ’2026.
multiple-turnover conditions function factors:                      (15) Winkler, M. E. (1987) Biosynthesis Histidine. Escherichia rate chemical step relative rate product                     coli Salmonella typhimurium: Cellular Molecular Biology
release, (ii) internal equilibrium constant chemical                  (Neidhardt, F. C., Ed.) pp 395âˆ’411, American Society step, active site, (iii) fraction active enzyme.37              Microbiology, Washington, DC. goal studies complete                       (16) Cho, Y., Sharma, V., Sacchettini, J. C. (2003) Crystal
kinetic mechanism MtATP-PRT, did attempt                             structure ATP phosphoribosyltransferase Mycobacterium
                                                                                  tuberculosis. J. Biol. Chem. 278, 8333âˆ’8339.
determine amplitude burst lower                          (17) Cho, Y., Ioerger, T. R., Sacchettini, J. C. (2008) Discovery
concentration MtATP-PRT.                                                       novel nitrobenzothiazole inhibitors Mycobacterium tuberculosis
c
 Scheme 3 shows sequential ordered kinetic mechanism,                         ATP phosphoribosyl transferase (HisG) virtual screening. J. binding ATP followed binding PRPP. Product                          Med. Chem. 51, 5984âˆ’5992.
release shown ordered, PPi dissociating ï¬?rst                        (18) Griffin, J. E., Gawronski, J. D., Dejesus, M. , Ioerger, T. R.,
followed PR-ATP. kinetic mechanism observed                           Akerley, B. J., Sassetti, C. M. (2011) High-resolution phenotypic SeATP-PRT.19                                                                 profiling defines genes essential mycobacterial growth d                                                                                 cholesterol catabolism. PLoS Pathog. 7, e1002251.
  concentration ATP M. tuberculosis unknown, cells typically contain 1 10 mM ATP. range                         (19) Parish, T. (2003) Starvation survival response Mycobacterium
corresponds roughly 5âˆ’50 times Km ATP.                                 tuberculosis. J. Bacteriol. 185, 6702âˆ’6706.


â– 
                                                                                    (20) Voll, M. J., Appella, E., Martin, R. G. (1967) Purification
                                                                                  composition studies phosphoribosyladenosine triphosphate:-
    REFERENCES                                                                    pyrophosphate phosphoribosyltransferase, enzyme histidine
 (1) Pardee,  B., Yates, R.  (1956) Control pyrimidine                 biosynthesis. J. Biol. Chem. 242, 1760âˆ’1767.
biosynthesis Escherichia coli feedback mechanism. J. Biol. Chem.            (21) Brashear, W. T., Parsons, S. M. (1975) Evidence 221, 757âˆ’770.                                                                     covalent intermediate a